| Literature DB >> 30233556 |
Xiaoyan Zhang1, Mengjun Tang1, Qian Zhou1, Jing Zhang1, Xingxing Yang1, Yushi Gao1.
Abstract
Handling and consumption of chicken meat are risk factors for human campylobacteriosis. This study was performed to describe the Campylobacter population in broiler carcasses and environmental samples throughout the slaughter process. Moreover, the genetic diversity and antimicrobial resistance of the Campylobacter strains were evaluated. Cloacal swabs, samples from carcasses at different stages, and environmental samples were collected thrice from the different flocks at the same abattoir located in Central Jiangsu, China. Campylobacter isolated from the three batches (n = 348) were identified as Campylobacter jejuni (n = 117) and Campylobacter coli (n = 151) by multiplex PCR. Characterization by multilocus sequence typing revealed a specific genotype of Campylobacter for each batch. Antimicrobial sensitivity to 18 antibiotics were analyzed for all selected strains according to the agar diffusion method recommended by the Clinical and Laboratory Standards Institute. Antibiotic susceptibility tests indicated that the majority of the tested isolates were resistant to quinolones (>89.7%). Less resistance to macrolide (59.8%), gentamicin (42.7%), amikacin (36.8%) was observed. Results showed that 94.0% of the tested strains demonstrated multidrug resistance.Entities:
Keywords: Campylobacter; MLST; antibiotic susceptibility; broiler; prevalence; slaughter process
Year: 2018 PMID: 30233556 PMCID: PMC6131577 DOI: 10.3389/fmicb.2018.02092
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Contamination ratio of Campylobacter during slaughter process in three batches.
| Sample site | No. of | |||||
|---|---|---|---|---|---|---|
| Batch 1 (Farm 1) | Batch 2 (Farm 2) | Batch 3 (Farm 3) | ||||
| Cloacal swabs | 19/30 (63.3%) | 0 | 0 | 20/20 (100.0%) | 0 | 3/22 (13.6%) |
| After plucking | 22/30 (73.3%) | 0 | 0 | 18/21 (85.7%) | 4/15 (26.7%) | 10/15 (66.7%) |
| After evisceration | 24/30 (80.0%) | 0 | 0 | 17/22 (77.3%) | 0 | 12/15 (80.0%) |
| After washing | 23/30 (76.7%) | 0 | 0 | 20/21 (95.2%) | 3/20 (15.0%) | 11/20 (55.0%) |
| After chilling | 7/8 (87.5%) | 0 | 1/10 (10.0%) | 9/10 (90.0%) | 0 | 10/10 (100.0%) |
| Operating table | 4/5 (80.0%) | 0 | 0 | 5/5 (100.0%) | 1/10 (10.0%) | 9/10 (90.0%) |
| Workers’ gloves | 3/5 (60.0%) | 0 | 1/5 (20.0%) | 4/5 (80.0%) | 2/5 (40.0%) | 2/5 (40.0%) |
| Water | 3/3 (100.0%) | 0 | 0 | 1/3 (33.3%) | 0 | 0/3/0 |
| Total | 105/141 (74.5%) | 96/107 (89.7%) | 67/100 (67.0%) | |||
The statistical contrast across the three batches (P-value).
| Sample site | Batch (Farm) (No. of | ||
|---|---|---|---|
| Cloacal swabs | 1 (19/30) | 2 (20/20) | 0.317 |
| 1 (19/30) | 3 (3/22) | 0.000∗ | |
| 2 (20/20) | 3 (3/22) | 0.000∗ | |
| After plucking | 1 (22/30) | 2 (18/21) | 0.295 |
| 1 (22/30) | 3 (14/15) | 0.118 | |
| 2 (18/21) | 3 (14/15) | 0.480 | |
| After evisceration | 1 (24/30) | 2 (17/22) | 0.814 |
| 1 (24/30) | 3 (12/15) | 1.000 | |
| 2 (17/22) | 3 (12/15) | 0.845 | |
| After washing | 1 (23/30) | 2 (20/21) | 0.076 |
| 1 (23/30) | 3 (14/20) | 0.602 | |
| 2 (20/21) | 3 (14/20) | 0.034∗ | |
| After chilling | 1 (7/8) | 2 (10/10) | 0.264 |
| 1 (7/8) | 3 (10/10) | 0.264 | |
| 2 (10/10) | 3 (10/10) | N | |
Number and percentages of resistance of Campylobacter isolates from three batches.
| Antibiotic group | Antibiotic name | No. of resistant | |||
|---|---|---|---|---|---|
| Batch 1 | Batch 2 | Batch 3 | Total | ||
| β-Lactams | AMP | 39/39 (100%) | 31/38 (81.6%) | 7/40 (17.5%) | 77/117 (65.8%) |
| AML | 39/39 (100%) | 31/38 (81.6%) | 7/40 (17.5%) | 77/117 (65.8%) | |
| CEX | 39/39 (100%) | 34/38 (89.5%) | 40/40 (100%) | 113/117 (96.6%) | |
| CRO | 39/39 (100%) | 20/38 (52.6%) | 40/40 (100%) | 99/117 (84.6%) | |
| Aminoglycosides | S | 39/39 (100%) | 31/38 (81.6%) | 40/40 (100%) | 109/117 (93.2%) |
| GEN | 39/39 (100%) | 5/38 (13.2%) | 6/40 (15.0%) | 50/117 (42.7%) | |
| K | 39/39 (100%) | 31/38 (81.6%) | 40/40 (100%) | 109/117 (93.2%) | |
| AMK | 39/39 (100%) | 2/38 (5.7%) | 2/40 (5.0%) | 42/117 (36.8%) | |
| TOB | 39/39 (100%) | 15/38 (39.5) | 40/40 (100%) | 94/117 (80.3%) | |
| Quinolones | NOR | 39/39 (100%) | 31/38 (81.6%) | 40/40 (100%) | 109/117 (93.2%) |
| CIP | 39/39 (100%) | 31/38 (81.6%) | 40/40 (100%) | 109/117 (93.2%) | |
| OFX | 39/39 (100%) | 31/38 (81.6%) | 40/40 (100%) | 109/117 (93.2%) | |
| NA | 39/39 (100%) | 31/38 (81.6%) | 40/40 (100%) | 109/117 (93.2%) | |
| ENR | 39/39 (100%) | 26/38 (68.4) | 40/40 (100%) | 105/117 (89.7%) | |
| Macrolide | E | 0 | 31/38 (81.6%) | 40/40 (100%) | 70/117 (59.8%) |
| AZM | 0 | 31/38 (81.6%) | 40/40 (100%) | 70/117 (59.8%) | |
| Tetracyclines | TE | 39/39 (100%) | 31/38 (81.6%) | 40/40 (100%) | 109/117 (93.2%) |
| Clindamycin | DA | 39/39 (100%) | 31/38 (81.6%) | 37/40 (92.5%) | 106/117 (90.6%) |
Resistance spectra of 117 Campylobacter to various antibiotic combinations.
| MAR index | No. of | Antibiotic | ||
|---|---|---|---|---|
| Batch 1 | Batch 2 | Batch 3 | ||
| 0 | 0 | 7 | 0 | – |
| 0.72 | 0 | 1 | 0 | AMP, AML, CEX, CRO, S, K, NOR, CIP, NA, E, AZM, TE, DA |
| 0.78 | 0 | 2 | 0 | AMP, AML, CEX, CRO, S, K, NOR, CIP, OFX, NA, E, AZM, TE, DA |
| 0.78 | 0 | 2 | 0 | AMP, AML, CEX, S, K, NOR, CIP, OFX, NA, ENR, E, AZM, TE, DA |
| 0.78 | 0 | 0 | 33 | CEX, CRO, S, K, TOB, NOR, CIP, OFX, NA, ENR, E, AZM, TE, DA |
| 0.83 | 0 | 5 | 0 | AMP, AML, CEX, S, K, TOB, NOR, CIP, OFX, NA, ENR, E, AZM, TE, DA |
| 0.83 | 0 | 2 | 0 | AMP, AML, CEX, CRO, S, K, TOB, NOR, CIP, NA, ENR, E, AZM, TE, DA |
| 0.83 | 0 | 4 | 0 | AMP, AML, CEX, CRO, S, K, NOR, CIP, OFX, NA, ENR, E, AZM, TE, DA |
| 0.83 | 0 | 0 | 2 | AMP, AML, CEX, S, GEN, K, TOB, NOR, CIP, OFX, NA, ENR, E, AZM, TE, |
| 0.83 | 0 | 1 | 0 | AMP, AML, CEX, S, GEN, K, TOB, NOR, CIP, OFX, NA, E, AZM, TE, DA |
| 0.89 | 0 | 9 | 0 | AMP, AML, CEX, CRO, S, K, TOB, NOR, CIP, OFX, NA, ENR, E, AZM, TE, DA |
| 0.89 | 0 | 1 | 0 | AMP, AML, CEX, GEN, K, AMK, TOB, NOR, CIP, OFX, NA, ENR, E, AZM, TE, DA |
| 0.89 | 0 | 1 | 0 | CEX, CRO, S, GEN, K, AMK, TOB, NOR, CIP, OFX, NA, ENR, E, AZM, TE, DA |
| 0.89 | 0 | 0 | 2 | AMP, AML, CEX, CRO, S, GEN, K, TOB, NOR, CIP, OFX, NA, ENR, E, AZM, TE |
| 0.89 | 39 | 0 | 0 | AMP, AML, CEX, CRO, S, GEN, K, AMK, TOB, NOR, CIP, OFX, NA, ENR, TE, DA |
| 0.94 | 0 | 3 | 1 | AMP, AML, CEX, CRO, S, GEN, K, TOB, NOR, CIP, OFX, NA, ENR, E, AZM, TE, DA |
| 1.00 | 0 | 0 | 2 | AMP, AML, CEX, CRO, S, GEN, K, AMK, TOB, NOR, CIP, OFX, NA, ENR, E, AZM, TE, DA |
Distributions of STs for 117 Campylobacter isolates.
| Batch | species | ST | ST-CC | Source | Number |
|---|---|---|---|---|---|
| 1 | 8089 | UA | Cloacal swab | 7 | |
| 8089 | UA | After plucking | 7 | ||
| 8089 | UA | After evisceration | 8 | ||
| 8089 | UA | After washing | 4 | ||
| 8089 | UA | After chilling | 7 | ||
| 8089 | UA | Operating table | 2 | ||
| 8089 | UA | Workers’ gloves | 2 | ||
| 8089 | UA | Water | 2 | ||
| 2 | 6186 | UA | After chilling | 1 | |
| 6186 | UA | Cloacal swab | 3 | ||
| 5511 | 828 | Cloacal swab | 1 | ||
| 6186 | UA | After plucking | 6 | ||
| 6186 | UA | After evisceration | 3 | ||
| 5511 | 828 | After washing | 1 | ||
| 825 | 828 | After washing | 1 | ||
| 6186 | UA | After washing | 4 | ||
| NEW1 | – | After washing | 2 | ||
| 825 | 828 | After chilling | 2 | ||
| 860 | 828 | After chilling | 3 | ||
| 6186 | UA | After chilling | 3 | ||
| 872 | 828 | Operating table | 2 | ||
| 860 | 828 | Operating table | 1 | ||
| 872 | 828 | Workers’ gloves | 4 | ||
| 6186 | UA | Water | 1 | ||
| 3 | 860 | 828 | Workers’ gloves | 2 | |
| 860 | 828 | Cloacal swab | 3 | ||
| 860 | 828 | After plucking | 6 | ||
| 830 | 828 | After plucking | 1 | ||
| 860 | 828 | After evisceration | 6 | ||
| 860 | 828 | After washing | 5 | ||
| 6186 | 828 | After washing | 1 | ||
| 860 | 828 | After chilling | 7 | ||
| 830 | 828 | After chilling | 1 | ||
| 825 | 828 | After chilling | 1 | ||
| 860 | 828 | Operating table | 4 | ||
| 825 | 828 | Operating table | 2 | ||
| 860 | 828 | Workers’ gloves | 1 |